Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASIA DS-ALL 2016 in newly diagnosed Down syndrome-associated acute lymphoblastic leukemia
jRCTs041180161Phase 2Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2018
01
Overview
Phase 2, open-label, single-arm trial in acute lymphoblastic leukemia (ALL), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Event-free survival. Started Aug 2018; status: active, not recruiting.
02
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on jRCTs041180161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180161.